- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Modular Medical, Inc.: Modular Medical to Participate in the iAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 on September 15-16, 2026 | 166 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / September 8, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| Fr | Modular Medical Aktie steigt nach Vertrag mit führendem Pharmacy Benefit Manager | 2 | Investing.com Deutsch | ||
| Fr | Modular Medical sichert sich Vertrag mit landesweitem US-Apothekenmanager | 1 | Investing.com Deutsch | ||
| Fr | Modular Medical secures contract with national U.S. pharmacy manager | 2 | Investing.com | ||
| Fr | Modular Medical, Inc.: Modular Medical Announces Contract with National U.S. Pharmacy Benefit Manager, Expanding Access to Pivot Tubeless Patch Pump | 309 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / September 4, 2026 / Modular Medical, Inc. ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the commercial... ► Artikel lesen | |
| 03.09. | Modular Medical, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.09. | Modular Medical, Inc.: Modular Medical Announces FDA Clearance of Pivot Tubeless Insulin Patch Pump Enhancements | 226 | ACCESS Newswire | Clearance Covers Software Enhancements for Greater Patient Flexibility and Pivot Customization SAN DIEGO, CA / ACCESS Newswire / September 3, 2026 / Modular Medical, Inc. ("Modular Medical" or "the... ► Artikel lesen | |
| MODULAR MEDICAL Aktie jetzt für 0€ handeln | |||||
| 03.09. | EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades | 2 | Benzinga.com | ||
| 02.09. | Modular Medical, Inc.: Registration is Now Open for Tribe Public's CEO Presentation and Q&A Webinar Event Titled 'The Road To Revenue: Modular Medical's Strategy For Launching Pivot' Featuring Modular Medical CEO - Friday, September 4, 2026 | 396 | ACCESS Newswire | Meet with Modular Medical CEO Jeb Besser.Discover The Pivot tubeless patch pump, a simple, wearable insulin delivery platform designed to provide continuous subcutaneous insulin infusion with both basal... ► Artikel lesen | |
| 02.09. | 6 After-Hours Healthcare Gainers: Universe Pharma, BioAffinity, Modular Medical, Telix Pharma & More | 666 | AFX News | BEIJING (dpa-AFX) - Today's after-hours gainers in the healthcare sector included Universe Pharmaceuticals, which drew attention after disclosing multiple Schedule 13G filings; bioAffinity Technologies... ► Artikel lesen | |
| 14.08. | Modular Medical, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 05.08. | Modular Medical, Inc.: Modular Medical to Participate in the Association of Diabetes Care & Education Specialists 2026 Annual Conference | 375 | ACCESS Newswire | SAN DIEGO, CA / ACCESS Newswire / August 5, 2026 / Modular Medical, Inc ("Modular Medical" or "the Company") (NASDAQ:MODD), a commercial-stage medical device company preparing for the full commercial... ► Artikel lesen | |
| 04.08. | Modular Medical to initiate first phase of Pivot pump launch in October | 1 | MassDevice | ||
| 03.08. | Modular Medical, Inc.: Modular Medical Announces Launch of Pivot Insulin Delivery System Across Five Key U.S. Markets Beginning October 2026 | 435 | ACCESS Newswire | First Phase of Strategic Rollout Targets Markets with Leading Insulin Pump Prescribers and Strong New Pump Adoption. Inizio will Provide Commercialization Expertise to Accelerate Awareness and Adoption... ► Artikel lesen | |
| 23.07. | Modular Medical forms advisory council for Pivot insulin pump | 3 | Investing.com | ||
| 23.07. | Modular Medical, Inc.: Modular Medical Announces Formation of Pivot Innovation Council and Appointment of Robert Gabbay, MD, PhD, FACP as Chairman | 321 | ACCESS Newswire | - Council to Provide Strategic Clinical Guidance on Commercialization, Patient Identification, Workflow Integration, and Evidence Generation SAN DIEGO, CA / ACCESS Newswire / July 23, 2026 / Modular... ► Artikel lesen | |
| 17.07. | Modular Medical inks IMO Health collab for insulin pump EHR integration | 2 | MassDevice | ||
| 16.07. | Modular Medical partners with IMO Health on patient identification tool | 5 | Investing.com | ||
| 16.07. | Modular Medical und IMO Health entwickeln Algorithmus zur Identifizierung von Diabetespatienten | 2 | Investing.com Deutsch | ||
| 16.07. | Modular Medical, Inc.: Modular Medical and IMO Health Launch Strategic Pilot to Enable Real Time Insulin Pump Patient Identification Into Electronic Health Records | 365 | ACCESS Newswire | Pilot Combines Clinician Guided Phenotypes with IMO Health's Unique Terminology Identifiers to Help Clinicians Easily Identify Patients Most Likely to Benefit from Pivot Insulin Pump TherapyAdvancing... ► Artikel lesen |
1 2 3 4 Weiter >>
65 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,176 | -1,22 % | Here's Why Teladoc's Integrated Care Business Deserves More Attention | ||
| SERNOVA BIOTHERAPEUTICS | 0,092 | +5,73 % | Stocks in Play: Sernova Biotherapeutics Inc. | ||
| CERENOME | 2,055 | -3,52 % | Cerenome, Inc.: Cerenome Reports Second Quarter 2026 Financial Results and Business Update | HOUSTON, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), a CNS oncology company advancing an integrated platform that combines precision diagnostics... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,080 | 0,00 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Second Quarter 2026 Financial Results and Provides a Corporate Update | SEATTLE, Aug. 7, 2026 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (Atossa or the Company), a clinical-stage biopharmaceutical company developing novel... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals: Historischer Wendepunkt - darum fliegt die Aktie! | Volltreffer: Bereits im Frühjahr hatte ich die positive Entwicklung bei Sonoma Pharmaceuticals antizipiert und die Nano-Cap-Aktie als hochinteressante Turnaround-Spekulation vorgestellt. Damals hatte... ► Artikel lesen | |
| TANDEM DIABETES | 16,400 | -0,61 % | Reasons to Retain Tandem Diabetes Stock in Your Portfolio Now | ||
| CO-DIAGNOSTICS | 1,110 | -0,89 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| QUIDELORTHO | 10,720 | +0,47 % | QuidelOrtho Corporation: QuidelOrtho Reports Second Quarter 2026 Financial Results | ? Total revenue grew 3% reported and 2% constant currency, primarily driven by Labs and Point of Care growth ?
? Excluding China, total revenue grew 6% both as... ► Artikel lesen | |
| VERU | 2,480 | 0,00 % | Veru Inc.: Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines' RASONQUE) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial | ||
| LIFEWARD | 7,310 | +2,10 % | Lifeward Ltd.: Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy | ||
| CLOVER HEALTH INVESTMENTS | 3,650 | -2,14 % | Clover Health (CLOV) Turns Profitable As Medicare Membership Explodes | ||
| SENSEONICS | 7,550 | +0,67 % | Senseonics sees activist investor take a major stake | ||
| TEMPEST THERAPEUTICS | 0,909 | +0,02 % | Tempest Therapeutics: Tempest Reports Second Quarter 2026 Financial Results and Provides Business Update | Executed a development collaboration with Senlang Biotechnology to advance certain in vivo CAR-T product candidates, including TPST-4003, a CD7-targeted next-generation in vivo CAR-T, with first patient... ► Artikel lesen | |
| NANO-X IMAGING | 0,770 | -1,29 % | Nano-X Imaging Ltd: Nanox Announces Second Quarter 2026 Financial Results and Provides Business Updates | PETACH TIKVA, Israel, Sept. 09, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (NASDAQ: NNOX) ("Nanox" or the "Company"), an innovative medical imaging technology company, today announced results for... ► Artikel lesen | |
| IMUNON | 1,340 | -0,74 % | Imunon schedules R&D day for Sept. 23 to discuss IL-12 therapy |
Das Unternehmen MODULAR MEDICAL INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 2,825 Euro und damit +0,53 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MODULAR MEDICAL INC finden Sie auf Wallstreet Online.